Previous Article | Next Article 
Journal of Virology, January 2002, p. 541-551, Vol. 76, No. 2
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.76.2.541-551.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Cloned Genomic DNA of Type 2 Porcine Circovirus Is Infectious When Injected Directly into the Liver and Lymph Nodes of Pigs: Characterization of Clinical Disease, Virus Distribution, and Pathologic Lesions
M. Fenaux,1 P. G. Halbur,2 G. Haqshenas,1 R. Royer,2 P. Thomas,2 P. Nawagitgul,2 M. Gill,3 T. E. Toth,1 and X. J. Meng1*
Department of Biomedical Sciences and Pathobiology, Center for Molecular Medicine and Infectious Diseases, College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0342,1
Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, Iowa 50011,2
Biological Research, Fort Dodge Animal Health, Inc., Fort Dodge, Iowa 50501-05183
Received 19 July 2001/
Accepted 11 October 2001
Infection of animals with a molecular viral clone is critical to study the genetic determinants of viral replication and virulence in the host. Type 2 porcine circovirus (PCV2) has been incriminated as the cause of postweaning multisystemic wasting syndrome (PMWS), an emerging disease in pigs. We report here for the first time the construction and use of an infectious molecular DNA clone of PCV2 to characterize the disease and pathologic lesions associated with PCV2 infection by direct in vivo transfection of pigs with the molecular clone. The PCV2 molecular clone was generated by ligating two copies of the complete PCV2 genome in tandem into the pBluescript SK (pSK) vector and was shown to be infectious in vitro when transfected into PK-15 cells. Forty specific-pathogen-free pigs at 4 weeks of age were randomly assigned to four groups of 10 each. Group 1 pigs served as uninoculated controls. Pigs in group 2 were each inoculated intranasally with about 1.9 x 105 50% tissue culture infective doses of a homogeneous PCV2 live virus stock derived from the molecular clone. Pigs in group 3 were each injected intrahepatically with 200 µg of the cloned PCV2 plasmid DNA, and pigs in group 4 were each injected into the superficial iliac lymph nodes with 200 µg of the cloned PCV2 plasmid DNA. Animals injected with the cloned PCV2 plasmid DNA developed infection resembling that induced by intranasal inoculation with PCV2 live virus stock. Seroconversion to PCV2-specific antibody was detected in the majority of pigs from the three inoculated groups at 35 days postinoculation (DPI). Viremia, beginning at 14 DPI and lasting 2 to 4 weeks, was detected in the majority of the pigs from all three inoculated groups. There were no remarkable clinical signs of PMWS in control or any of the inoculated pigs. Gross lesions in pigs of the three inoculated groups were similar and were characterized by systemically enlarged, tan lymph nodes and lungs that failed to collapse. Histopathological lesions and PCV2-specific antigen were detected in numerous tissues and organs, including brain, lung, heart, kidney, tonsil, lymph nodes, spleen, ileum, and liver of infected pigs. This study more definitively characterizes the clinical course and pathologic lesions exclusively attributable to PCV2 infection. The data from this study indicate that the cloned PCV2 genomic DNA may replace infectious virus for future PCV2 pathogenesis and immunization studies. The data also suggest that PCV2, although essential for development of PMWS, may require other factors or agents to induce the full spectrum of clinical signs and lesions associated with advanced cases of PMWS.
* Corresponding author. Mailing address: Center for Molecular Medicine and Infectious Diseases, Virginia Polytechnic Institute and State University, 1410 Prices Fork Rd., Blacksburg, VA 24061-0342. Phone: (540) 231-6912. Fax: (540) 231-3426. E-mail: xjmeng{at}vt.edu.
Journal of Virology, January 2002, p. 541-551, Vol. 76, No. 2
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.76.2.541-551.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Shen, H.-G., Zhou, J.-Y., Huang, Z.-Y., Guo, J.-Q., Xing, G., He, J.-L., Yan, Y., Gong, L.-Y.
(2008). Protective immunity against porcine circovirus 2 by vaccination with ORF2-based DNA and subunit vaccines in mice. J. Gen. Virol.
89: 1857-1865
[Abstract]
[Full Text]
-
Opriessnig, T., Patterson, A. R., Elsener, J., Meng, X. J., Halbur, P. G.
(2008). Influence of Maternal Antibodies on Efficacy of Porcine Circovirus Type 2 (PCV2) Vaccination To Protect Pigs from Experimental Infection with PCV2. CVI
15: 397-401
[Abstract]
[Full Text]
-
Opriessnig, T., Meng, X.-J., Halbur, P. G.
(2007). Porcine Circovirus Type 2 associated disease: Update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. jvdi
19: 591-615
[Abstract]
[Full Text]
-
Ma, C.-M., Hon, C.-C., Lam, T.-Y., Li, V. Y.-Y., Wong, C. K.-W., de Oliveira, T., Leung, F. C.-C.
(2007). Evidence for recombination in natural populations of porcine circovirus type 2 in Hong Kong and mainland China. J. Gen. Virol.
88: 1733-1737
[Abstract]
[Full Text]
-
Correa, A. M. R., Zlotowski, P., de Barcellos, D. E. S. N., da Cruz, C. E. F., Driemeier, D.
(2007). Brain lesions in pigs affected with postweaning multisystemic wasting syndrome. jvdi
19: 109-112
[Abstract]
[Full Text]
-
Opriessnig, T., McKeown, N. E., Zhou, E.-M., Meng, X.-J., Halbur, P. G.
(2006). Genetic and experimental comparison of porcine circovirus type 2 (PCV2) isolates from cases with and without PCV2-associated lesions provides evidence for differences in virulence.. J. Gen. Virol.
87: 2923-2932
[Abstract]
[Full Text]
-
Cheung, A. K.
(2006). Rolling-Circle Replication of an Animal Circovirus Genome in a Theta-Replicating Bacterial Plasmid in Escherichia coli.. J. Virol.
80: 8686-8694
[Abstract]
[Full Text]
-
Opriessnig, T., McKeown, N. E., Harmon, K. L., Meng, X. J., Halbur, P. G.
(2006). Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine.. CVI
13: 923-929
[Abstract]
[Full Text]
-
Liu, J., Chen, I., Du, Q., Chua, H., Kwang, J.
(2006). The ORF3 Protein of Porcine Circovirus Type 2 Is Involved in Viral Pathogenesis In Vivo.. J. Virol.
80: 5065-5073
[Abstract]
[Full Text]
-
Opriessnig, T., Fenaux, M., Thomas, P., Hoogland, M. J., Rothschild, M. F., Meng, X. J., Halbur, P. G.
(2006). Evidence of Breed-dependent Differences in Susceptibility to Porcine Circovirus Type-2-associated Disease and Lesions. Vet Pathol
43: 281-293
[Abstract]
[Full Text]
-
McKeown, N. E., Opriessnig, T., Thomas, P., Guenette, D. K., Elvinger, F., Fenaux, M., Halbur, P. G., Meng, X. J.
(2005). Effects of Porcine Circovirus Type 2 (PCV2) Maternal Antibodies on Experimental Infection of Piglets with PCV2. CVI
12: 1347-1351
[Abstract]
[Full Text]
-
Liu, J., Chen, I., Kwang, J.
(2005). Characterization of a Previously Unidentified Viral Protein in Porcine Circovirus Type 2-Infected Cells and Its Role in Virus-Induced Apoptosis. J. Virol.
79: 8262-8274
[Abstract]
[Full Text]
-
Fenaux, M., Opriessnig, T., Halbur, P. G., Elvinger, F., Meng, X. J.
(2004). Two Amino Acid Mutations in the Capsid Protein of Type 2 Porcine Circovirus (PCV2) Enhanced PCV2 Replication In Vitro and Attenuated the Virus In Vivo. J. Virol.
78: 13440-13446
[Abstract]
[Full Text]
-
Fenaux, M., Opriessnig, T., Halbur, P. G., Xu, Y., Potts, B., Meng, X.-J.
(2004). Detection and in vitro and in vivo characterization of porcine circovirus DNA from a porcine-derived commercial pepsin product. J. Gen. Virol.
85: 3377-3382
[Abstract]
[Full Text]
-
Opriessnig, T., Thacker, E. L., Yu, S., Fenaux, M., Meng, X.-J., Halbur, P. G.
(2004). Experimental Reproduction of Postweaning Multisystemic Wasting Syndrome in Pigs by Dual Infection with Mycoplasma hyopneumoniae and Porcine Circovirus Type 2. Vet Pathol
41: 624-640
[Abstract]
[Full Text]
-
Krakowka, S., Ellis, J., McNeilly, F., Meehan, B., Oglesbee, M., Alldinger, S., Allan, G.
(2004). Features of Cell Degeneration and Death in Hepatic Failure and Systemic Lymphoid Depletion Characteristic of Porcine Circovirus-2-associated Postweaning Multisystemic Wasting Disease. Vet Pathol
41: 471-481
[Abstract]
[Full Text]
-
Fenaux, M., Opriessnig, T., Halbur, P. G., Elvinger, F., Meng, X. J.
(2004). A Chimeric Porcine Circovirus (PCV) with the Immunogenic Capsid Gene of the Pathogenic PCV Type 2 (PCV2) Cloned into the Genomic Backbone of the Nonpathogenic PCV1 Induces Protective Immunity against PCV2 Infection in Pigs. J. Virol.
78: 6297-6303
[Abstract]
[Full Text]
-
Roca, M., Balasch, M., Segales, J., Calsamiglia, M., Viaplana, E., Urniza, A., Hattermann, K., Mankertz, A., Plana-Duran, J., Domingo, M.
(2004). In vitro and in vivo characterization of an infectious clone of a European strain of porcine circovirus type 2. J. Gen. Virol.
85: 1259-1266
[Abstract]
[Full Text]
-
de Boisseson, C., Beven, V., Bigarre, L., Thiery, R., Rose, N., Eveno, E., Madec, F., Jestin, A.
(2004). Molecular characterization of Porcine circovirus type 2 isolates from post-weaning multisystemic wasting syndrome-affected and non-affected pigs. J. Gen. Virol.
85: 293-304
[Abstract]
[Full Text]
-
Fenaux, M., Opriessnig, T., Halbur, P. G., Meng, X. J.
(2003). Immunogenicity and Pathogenicity of Chimeric Infectious DNA Clones of Pathogenic Porcine Circovirus Type 2 (PCV2) and Nonpathogenic PCV1 in Weanling Pigs. J. Virol.
77: 11232-11243
[Abstract]
[Full Text]
-
Opriessnig, T., Yu, S., Gallup, J. M., Evans, R. B., Fenaux, M., Pallares, F., Thacker, E. L., Brockus, C. W., Ackermann, M. R., Thomas, P., Meng, X. J., Halbur, P. G.
(2003). Effect of Vaccination with Selective Bacterins on Conventional Pigs Infected with Type 2 Porcine Circovirus. Vet Pathol
40: 521-529
[Abstract]
[Full Text]
-
(2002). . Vet Pathol
39: 416-417
[Full Text]
Copyright © 2002 by the American Society for Microbiology. All rights reserved.